Get started
RocketTickers

FDA Approves BAVENCIO as First-Line Maintenance Treatment for Pa

Long
Pfizer (NYSE:PFE)  
RocketTickers  
NYSE:PFE   Pfizer
Beyond Technical Analysis
5
0
beyondta
PFE: Pfizer Inc.
2020-06-30 19:30:00
FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.